Rite Aid (RAD) April Comps Rose 5%; Front-End Up 4.7%

Go back to Rite Aid (RAD) April Comps Rose 5%; Front-End Up 4.7%

Rite-Aid (RAD): Script Growth May Be Sign of Strong Comps, Says Goldman

May 1, 2014 2:21 PM EDT

Goldman Sachs maintained a Buy rating on Rite-Aid (NYSE: RAD) with a price target of $9.00. Rite-Aid's 1QFY15 adj. EBITDA estimate was raised to $311 million from $303 million. Analyst Robert P. Jones thinks an inflection in... More